Longeveron Inc (LGVN)
1.75
-0.06
(-3.31%)
USD |
NASDAQ |
May 03, 16:00
1.72
-0.03
(-1.71%)
After-Hours: 20:00
Longeveron Cash from Financing (TTM): 5.262M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.262M |
September 30, 2023 | -0.346M |
June 30, 2023 | -0.323M |
March 31, 2023 | -0.385M |
December 31, 2022 | -0.509M |
September 30, 2022 | 18.20M |
June 30, 2022 | 18.23M |
Date | Value |
---|---|
March 31, 2022 | 18.36M |
December 31, 2021 | 45.17M |
September 30, 2021 | 26.62M |
June 30, 2021 | 26.63M |
March 31, 2021 | 27.10M |
December 31, 2020 | 1.575M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.509M
Minimum
Dec 2022
45.17M
Maximum
Dec 2021
14.28M
Average
18.20M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Palatin Technologies Inc | 5.553M |
BioSig Technologies Inc | 17.33M |
Adial Pharmaceuticals Inc | 4.132M |
Outset Medical Inc | 43.65M |
MSP Recovery Inc | 29.02M |